- Home
- NTIC vs GALT Comparison
NTIC vs GALT Comparison
Compare NTIC & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTIC
- GALT
- Stock Information
- Founded
- NTIC 1970
- GALT 2000
- Country
- NTIC United States
- GALT United States
- Employees
- NTIC N/A
- GALT N/A
- Industry
- NTIC Industrial Specialties
- GALT Biotechnology: Pharmaceutical Preparations
- Sector
- NTIC Industrials
- GALT Health Care
- Exchange
- NTIC Nasdaq
- GALT Nasdaq
- Market Cap
- NTIC 71.5M
- GALT 83.5M
- IPO Year
- NTIC N/A
- GALT N/A
- Fundamental
- Price
- NTIC $7.95
- GALT $2.79
- Analyst Decision
- NTIC
- GALT Buy
- Analyst Count
- NTIC 0
- GALT 2
- Target Price
- NTIC N/A
- GALT $6.00
- AVG Volume (30 Days)
- NTIC 87.1K
- GALT 664.5K
- Earning Date
- NTIC 07-10-2025
- GALT 08-12-2025
- Dividend Yield
- NTIC 0.49%
- GALT N/A
- EPS Growth
- NTIC N/A
- GALT N/A
- EPS
- NTIC 0.31
- GALT N/A
- Revenue
- NTIC $85,268,129.00
- GALT N/A
- Revenue This Year
- NTIC $2.05
- GALT N/A
- Revenue Next Year
- NTIC $4.70
- GALT N/A
- P/E Ratio
- NTIC $25.91
- GALT N/A
- Revenue Growth
- NTIC 3.46
- GALT N/A
- 52 Week Low
- NTIC $6.75
- GALT $0.73
- 52 Week High
- NTIC $15.09
- GALT $3.90
- Technical
- Relative Strength Index (RSI)
- NTIC 49.99
- GALT 68.94
- Support Level
- NTIC $7.84
- GALT $2.77
- Resistance Level
- NTIC $8.23
- GALT $2.97
- Average True Range (ATR)
- NTIC 0.47
- GALT 0.20
- MACD
- NTIC -0.03
- GALT 0.04
- Stochastic Oscillator
- NTIC 36.25
- GALT 91.11
About NTIC Northern Technologies International Corporation
Northern Technologies International Corp, or NTIC is a United States-based firm that develops and markets environmentally beneficial products and services world-wide either directly or through a network of joint ventures, distributors, and agents. It operates through two segments which include ZERUST products and services and Nature-Tec products. Its main business is providing corrosion prevention solutions that are marketed under the ZERUST brand. The company also sells a portfolio of bio-based and biodegradable (compostable) polymer resin compounds and finished products marketed under the Nature-Tec brand. The ZERUST brand generates a vast majority of the revenue for the company.
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.